Global Development Plan for Deferiprone by CorMedix Inc. (June 2011)

This document is a confidential global development plan for Deferiprone, prepared by CorMedix Inc. It outlines the company's strategy and steps for the worldwide development and regulatory approval of Deferiprone, a pharmaceutical product. The plan includes project management, regulatory, and executive approvals, and details the responsibilities of CorMedix Inc. in managing the development process. The document is intended for internal use and requires written permission from CorMedix Inc. for any disclosure or reproduction.